DNLIDenali Therapeutics Inc.

Nasdaq denalitherapeutics.com


$ 20.36 $ -0.24 (-1.17 %)    

Wednesday, 15-May-2024 13:46:10 EDT
QQQ $ 452.00 $ 3.10 (0.69 %)
DIA $ 398.46 $ 0.58 (0.15 %)
SPY $ 528.49 $ 2.57 (0.49 %)
TLT $ 92.18 $ 0.34 (0.37 %)
GLD $ 220.94 $ 1.70 (0.78 %)
$ 19.75
$ 20.60
$ 0.00 x 0
$ 0.00 x 0
$ 20.06 - $ 20.74
$ 14.56 - $ 33.31
920,657
na
2.95B
$ 1.30
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-07-2024 03-31-2024 10-Q
2 02-28-2024 12-31-2023 10-K
3 11-07-2023 09-30-2023 10-Q
4 08-08-2023 06-30-2023 10-Q
5 05-08-2023 03-31-2023 10-Q
6 02-27-2023 12-31-2022 10-K
7 11-03-2022 09-30-2022 10-Q
8 08-08-2022 06-30-2022 10-Q
9 05-05-2022 03-31-2022 10-Q
10 02-28-2022 12-31-2021 10-K
11 11-04-2021 09-30-2021 10-Q
12 08-04-2021 06-30-2021 10-Q
13 05-05-2021 03-31-2021 10-Q
14 02-26-2021 12-31-2020 10-K
15 11-05-2020 09-30-2020 10-Q
16 08-07-2020 06-30-2020 10-Q
17 05-07-2020 03-31-2020 10-Q
18 02-27-2020 12-31-2019 10-K
19 11-06-2019 09-30-2019 10-Q
20 08-06-2019 06-30-2019 10-Q
21 05-08-2019 03-31-2019 10-Q
22 03-12-2019 12-31-2018 10-K
23 11-08-2018 09-30-2018 10-Q
24 08-09-2018 06-30-2018 10-Q
25 05-11-2018 03-31-2018 10-Q
26 03-19-2018 12-31-2017 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 wedbush-maintains-outperform-on-denali-therapeutics-lowers-price-target-to-30

Wedbush analyst Laura Chico maintains Denali Therapeutics (NASDAQ:DNLI) with a Outperform and lowers the price target from $...

 stifel-maintains-hold-on-denali-therapeutics-lowers-price-target-to-22

Stifel analyst Paul Mattels maintains Denali Therapeutics (NASDAQ:DNLI) with a Hold and lowers the price target from $26 to ...

 hc-wainwright--co-reiterates-buy-on-denali-therapeutics-maintains-95-price-target

HC Wainwright & Co. analyst Andrew Fein reiterates Denali Therapeutics (NASDAQ:DNLI) with a Buy and maintains $95 price ...

 denali-therapeutics-q1-eps-068-beats-070-estimate

Denali Therapeutics (NASDAQ:DNLI) reported quarterly losses of $(0.68) per share which beat the analyst consensus estimate of $...

 ubs-maintains-buy-on-denali-therapeutics-lowers-price-target-to-32

UBS analyst Esther Rajavelu maintains Denali Therapeutics (NASDAQ:DNLI) with a Buy and lowers the price target from $70 to $32.

 denali-therapeutics-inc-files-prospectus-related-to-offer-and-resale-from-time-to-time-of-up-to-293m-shares-by-the-selling-stockholders

- SEC Filing

 goldman-sachs-maintains-buy-on-denali-therapeutics-lowers-price-target-to-50

Goldman Sachs analyst Salveen Richter maintains Denali Therapeutics (NASDAQ:DNLI) with a Buy and lowers the price target fro...

 hc-wainwright--co-maintains-buy-on-denali-therapeutics-lowers-price-target-to-95

HC Wainwright & Co. analyst Andrew Fein maintains Denali Therapeutics (NASDAQ:DNLI) with a Buy and lowers the price targ...

 wedbush-reiterates-outperform-on-denali-therapeutics-maintains-31-price-target

Wedbush analyst Laura Chico reiterates Denali Therapeutics (NASDAQ:DNLI) with a Outperform and maintains $31 price target.

 why-helix-energy-solutions-shares-are-trading-lower-by-11-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Helix Energy Solutions Group, Inc. (NYSE: HLX) fell sharply during Tuesday’s session following weak earnings.

 norwegian-cruise-line-posts-strong-sales-joins-hims--hers-health-sterling-infrastructure-and-other-big-stocks-moving-higher-on-tuesday

U.S. stocks were mixed, with the Dow Jones index falling around 100 points on Tuesday.

 denali-therapeutics-q4-2023-gaap-eps-086-misses-081-estimate

Denali Therapeutics (NASDAQ:DNLI) reported quarterly losses of $(0.86) per share which missed the analyst consensus estimate of...

 hc-wainwright--co-reiterates-buy-on-denali-therapeutics-maintains-105-price-target

HC Wainwright & Co. analyst Andrew Fein reiterates Denali Therapeutics (NASDAQ:DNLI) with a Buy and maintains $105 price...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION